Company: MDCXW
Filing Date: 2025-12-08
Form Type: 424B3
Source: 0001062993-25-017231
Chunk: 5

Company: Medicus Pharma Ltd.
Filing Date: 2025-12-08
Form: 424B3
Chunk 5
---
 |               - |            $1,500,905 |

The Company may cause Yorkville to purchase additional Common Shares under the SEPA from time to time, subject to the satisfaction or waiver of the conditions and limitations set forth in the SEPA. The Company has used part of the net proceeds from the SEPA Advances to prepay a portion of the debenture the Company has outstanding with Yorkville, as described in that certain Current Report on Form 8-K dated September 18, 2025. The Common Shares were issued and sold to Yorkville in reliance upon the exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), afforded by Section 4(a)(2) of the Securities Act. The Company is relying on this exemption from registration based in part on representations made by Yorkville in the SEPA. Yorkville may resell the Common Shares it has purchased from the Company under the SEPA from time to time pursuant to an effective registration statement which has been filed by the Company in accordance with its requirements under the SEPA for such purposes

This report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

​

| Exhibit 
 No.     | Description                                                                  |
| 4.1     | Form of Series C Warrant                                                     |
| 4.2     | Form of Series D Warrant                                                     |
| 10.1    | Form of Warrant Inducement Agreement                                         |
| 104.1   | Cover Page Interactive Data File (embedded within the inline XBRL document). |

Forward-Looking Statements

Certain information in this news release constitutes "forward-looking information" under applicable securities laws. "Forward-looking information" is defined as disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action and includes, without limitation, statements regarding the closing of the Company's issuance of the New Warrants and the timing thereof, any sales by the investor of Common Shares underlying the Existing Warrants or the New Warrants, the timing and effectiveness of the Registration Statement, whether the Shareholder Approval will be obtained, if required and any future sales of Common Shares under the SEPA to